Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypothermic neuroprotection.

A J Gunn1, M Thoresen

  • 1Dept of Physiology, The University of Auckland, New Zealand. aj.gunn@auckland.ac.nz

Neurorx : the Journal of the American Society for Experimental Neurotherapeutics
|March 24, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Meta-analysis of the effects of age at first calving on production outcomes, calving difficulty, and reproduction in dairy heifers.

Journal of dairy science·2026
Same author

Safety, feasibility, and technical success of percutaneous cryoablation to treat vascular anomalies of the extremities.

Clinical radiology·2025
Same author

Safety and Feasibility of Endovascular Management of Pediatric Dialysis Access.

Cardiovascular and interventional radiology·2025
Same author

Paediatric sclerotherapy of vascular anomalies of the hand and digits.

Clinical radiology·2025
Same author

Fetal heart rate responses in chronic hypoxaemia with superimposed repeated hypoxaemia consistent with early labour: a controlled study in fetal sheep.

BJOG : an international journal of obstetrics and gynaecology·2023
Same author

Protein Intake and the Risk of Pre-Frailty and Frailty in Norwegian Older Adults. The Tromsø Study 1994-2016.

The Journal of frailty & aging·2022
Same journal

Pediatric neurotherapy.

NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics·2013
Same journal

Drug development in critical times.

NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics·2006
Same journal

Spinal muscular atrophy: a test case for drug development in orphan diseases.

NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics·2006
Same journal

Community neurorehabilitation: a synthesis of current evidence and future research directions.

NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics·2006
Same journal

Issues in selecting outcome measures to assess functional recovery after stroke.

NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics·2006
Same journal

Behavioral tests for preclinical intervention assessment.

NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics·2006
See all related articles

Therapeutic hypothermia, or cooling, can protect the brain after birth asphyxia or cardiac arrest by reducing delayed neuronal loss. While beneficial for some, improving hypothermia treatment effectiveness remains a key challenge.

Area of Science:

  • Neuroscience
  • Critical Care Medicine
  • Perinatal Medicine

Background:

  • Hypoxia-ischemia can cause delayed neuronal loss through complex biochemical cascades.
  • Injury progresses through a latent phase followed by secondary deterioration involving cytotoxins and metabolic failure.
  • Therapeutic hypothermia has long been investigated for its neuroprotective potential.

Purpose of the Study:

  • To evaluate the neuroprotective effects of therapeutic hypothermia following hypoxic-ischemic events.
  • To assess the safety and efficacy of cooling therapies in neonatal encephalopathy and adult cardiac arrest.

Main Methods:

  • Studies investigated moderate cerebral hypothermia initiated early and maintained for sufficient duration.
  • Two large controlled trials assessed head cooling (mild hypothermia) and whole-body cooling (moderate hypothermia).

Related Experiment Videos

  • Safety in intensive care and long-term outcomes (18 months) were evaluated in neonatal populations.

    • Main Results:

    • Moderate cerebral hypothermia demonstrated potent, long-lasting neuroprotection in animal models.
    • Post-resuscitation cooling was found to be generally safe in intensive care settings.
    • Cooling reduced death or disability in infants with neonatal encephalopathy, but only a subset benefited.

    Conclusions:

    • Therapeutic hypothermia is a viable neuroprotective strategy after hypoxic-ischemic insults.
    • Current cooling protocols show benefit in specific patient populations, particularly neonates.
    • Future research should focus on enhancing the effectiveness of hypothermia treatments to benefit more patients.